Best treatments for hot flashes
2 products may treat hot flashes, spanning FDA drug classes such as neurokinin 3 receptor antagonist. The current highest-rated option is veozah. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 2 drugs we list for hot flashes, none are yet flagged as generics in our price data, spanning classes such as neurokinin 3 receptor antagonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hot flashes — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | Neurokinin 3 Receptor Antagonist | No data | — | View → | |
| 2 | Not yet rated | Prescription | Capsule | — | No data | — | View → |
Full ranking · 2 treatments
veozah
Boxed warningPrescriptionFDA-sourced
Veozah (Fezolinetant) is a neurokinin 3 receptor antagonist used to treat Hot Flashes.
lynkuet
PrescriptionFDA-sourced
Lynkuet (Elinzanetant) is a medication used to treat Menopause, Hot Flashes.
Frequently asked
- What treats hot flashes?
- Our catalog lists 2 products that may treat hot flashes, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is veozah.
- What is the best-rated treatment for hot flashes?
- By our independent recall-safety rating — not an efficacy measure — veozah ranks highest among the products we list for hot flashes. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat hot flashes?
- Treatments for hot flashes span FDA drug classes including neurokinin 3 receptor antagonist. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.